HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation
NYSE:DOC • US42250P1030
Current stock price
16.55 USD
-0.04 (-0.24%)
At close:
16.7509 USD
+0.2 (+1.21%)
After Hours:
This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DOC Profitability Analysis
1.1 Basic Checks
- DOC had positive earnings in the past year.
- In the past year DOC had a positive cash flow from operations.
- Each year in the past 5 years DOC has been profitable.
- Each year in the past 5 years DOC had a positive operating cash flow.
1.2 Ratios
- DOC has a Return On Assets (0.35%) which is comparable to the rest of the industry.
- DOC has a Return On Equity of 0.94%. This is comparable to the rest of the industry: DOC outperforms 50.00% of its industry peers.
- DOC has a Return On Invested Capital (2.24%) which is in line with its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.11%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- DOC has a Profit Margin (2.50%) which is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of DOC has declined.
- The Operating Margin of DOC (19.31%) is comparable to the rest of the industry.
- DOC's Operating Margin has improved in the last couple of years.
- DOC has a worse Gross Margin (60.00%) than 68.03% of its industry peers.
- DOC's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. DOC Health Analysis
2.1 Basic Checks
- DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for DOC has been reduced compared to 1 year ago.
- The number of shares outstanding for DOC has been increased compared to 5 years ago.
- Compared to 1 year ago, DOC has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.32, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- DOC has a Altman-Z score (0.32) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.27 is on the high side and indicates that DOC has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.27, DOC is in line with its industry, outperforming 49.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.32 |
ROIC/WACC0.37
WACC6.01%
2.3 Liquidity
- A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC has a worse Current ratio (0.48) than 74.59% of its industry peers.
- A Quick Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC has a Quick ratio of 0.48. This is in the lower half of the industry: DOC underperforms 74.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. DOC Growth Analysis
3.1 Past
- The earnings per share for DOC have decreased by 0.00% in the last year.
- Measured over the past years, DOC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.06% on average per year.
- The Revenue has been growing slightly by 4.52% in the past year.
- The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- Based on estimates for the next years, DOC will show a small growth in Earnings Per Share. The EPS will grow by 0.77% on average per year.
- Based on estimates for the next years, DOC will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. DOC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 47.29, which means the current valuation is very expensive for DOC.
- DOC's Price/Earnings is on the same level as the industry average.
- DOC is valuated expensively when we compare the Price/Earnings ratio to 24.75, which is the current average of the S&P500 Index.
- DOC is valuated quite expensively with a Price/Forward Earnings ratio of 76.21.
- DOC's Price/Forward Earnings is on the same level as the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 22.10. DOC is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.29 | ||
| Fwd PE | 76.21 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 60.66% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.02 |
4.3 Compensation for Growth
- A cheap valuation may be justified as DOC's earnings are expected to decrease with -9.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
5. DOC Dividend Analysis
5.1 Amount
- DOC has a Yearly Dividend Yield of 7.27%, which is a nice return.
- Compared to an average industry Dividend Yield of 7.54, DOC pays a bit more dividend than its industry peers.
- DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.27% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Fundamentals: All Metrics, Ratios and Statistics
16.55
-0.04 (-0.24%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.68%
Inst Owner Change-96.4%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap11.51B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.83 (19.82%)
Short Float %4.64%
Short Ratio3.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.27% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)0%
PT rev (3m)-4.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)-17.76%
EPS NY rev (3m)-18.7%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.29 | ||
| Fwd PE | 76.21 | ||
| P/S | 4.08 | ||
| P/FCF | N/A | ||
| P/OCF | 9.19 | ||
| P/B | 1.53 | ||
| P/tB | 1.7 | ||
| EV/EBITDA | 13.02 |
EPS(TTM)0.35
EY2.11%
EPS(NY)0.22
Fwd EY1.31%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY10.88%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | N/A |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 130.74% | ||
| Cap/Sales | 49.05% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.32 |
F-Score6
WACC6.01%
ROIC/WACC0.37
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.56%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 47.29 and the Price/Book (PB) ratio is 1.53.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.